Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Neurologix, Inc. is a development-stage company engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system utilizing gene therapies. The Company’s initial development efforts are focused on gene therapy for treating Parkinson’s disease, epilepsy and Huntington’s disease. Neurologix’s core technology, “NLX,” is currently being tested in a Company-sponsored Phase I human clinical trial to treat Parkinson’s disease. ( www.neurologix.net )
Neurologix , Inc.
One Bridge Plaza
Fort Lee, New Jersey 07024
USA
Tel: (201) 592-6451
Fax: (201) 592-0366